Xatmep (methotrexate oral solution) — Medical Mutual
Polyarticular juvenile idiopathic arthritis (pJIA)
Initial criteria
- Patient is age < 18 years; AND
- Patient has tried oral methotrexate tablets; OR
- Patient cannot swallow tablets
Reauthorization criteria
- Response to therapy is required for continuation of therapy
Approval duration
1 year